BIOMAT Database Logo BIOMAT Database Logo

[Use of ethambutol in combined chemotherapy of patients with destructive forms of tuberculosis]. 1973

S A Markovskii, and V S Golanov, and Ia A Chatskii

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012030 Refractive Errors Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus. Ametropia,Refractive Disorders,Ametropias,Disorder, Refractive,Disorders, Refractive,Error, Refractive,Errors, Refractive,Refractive Disorder,Refractive Error
D012164 Retinal Diseases Diseases involving the RETINA. Disease, Retinal,Diseases, Retinal,Retinal Disease
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

S A Markovskii, and V S Golanov, and Ia A Chatskii
[Immediate results of ethambutol chemotherapy of patients with disseminated chronic destructive pulmonary tuberculosis].
October 1973, Vrachebnoe delo,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[Intravenous chemotherapy of patients with destructive forms of pulmonary tuberculosis].
January 1971, Problemy tuberkuleza,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
December 1974, Klinicheskaia meditsina,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[Ethambutol in combined chemotherapy of pulmonary tuberculosis].
January 1970, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[Use of ethambutol in higher and regular doses in the treatment of patients with chronic destructive forms of pulmonary tuberculosis].
January 1988, Problemy tuberkuleza,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
October 1989, Vrachebnoe delo,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
July 1983, Problemy tuberkuleza,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
October 1985, Vrachebnoe delo,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[The tuberculostatic test in patients with chronic destructive pulmonary tuberculosis during chemotherapy with ethambutol combined with drugs of the first and second series].
April 1974, Antibiotiki,
S A Markovskii, and V S Golanov, and Ia A Chatskii
[Rifampicin and ethambutol in the treatment of chronic, destructive forms of pulmonary tuberculosis].
January 1972, Giornale italiano di chemioterapia,
Copied contents to your clipboard!